SPECIFICITY OF BIOCHEMICAL BLOOD ANALYSIS IN MYOCARDIAL INFARCTION

Abstract

This article analyzes the specificity of biochemical blood markers in the diagnosis and monitoring of myocardial infarction (MI). Special attention is given to the kinetics, diagnostic accuracy, and clinical relevance of cardiac-specific enzymes and proteins, including troponins, creatine kinase-MB, myoglobin, and emerging novel biomarkers. The discussion highlights the advantages and limitations of these markers in differentiating myocardial infarction from other cardiac and non-cardiac pathologies, and the role of multimodal biomarker strategies for improving diagnostic precision in acute coronary syndromes.